RTW Biotech Opportunities (LON:RTW – Get Free Report)’s stock price traded down 0.5% during trading on Wednesday . The company traded as low as GBX 1.29 ($0.02) and last traded at GBX 1.30 ($0.02). 2,421,589 shares traded hands during trading, an increase of 203% from the average session volume of 799,335 shares. The stock had previously closed at GBX 1.31 ($0.02).
RTW Biotech Opportunities Price Performance
The firm has a market capitalization of £5.03 million, a P/E ratio of 3.62 and a beta of 0.60. The business’s 50-day moving average is GBX 1.32 and its 200 day moving average is GBX 1.28.
About RTW Biotech Opportunities
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- The “How” and “Why” of Investing in 5G Stocks
- United Airlines Soars on Earnings Beat
- There Are Different Types of Stock To Invest In
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Insider Buying Explained: What Investors Need to Know
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
